SCHEMBL30255686

SCHEMBL30255686

OB(O)Oc1cnn(C2CC2)c1

nearest known ligand 0.36

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ ACHE P22303 3/20 0.36
▸ KDM4C Q9H3R0 3/20 0.34
▸ KDM4E B2RXH2 1/20 0.34
▸ KDM4A O75164 1/20 0.34
▸ KDM5C P41229 1/20 0.34
▸ KDM4D Q6B0I6 1/20 0.34
▸ PSMB8 P28062 1/20 0.33
▸ PSMB9 P28065 1/20 0.33
▸ MPO P05164 1/20 0.32
▸ PIK3CD O00329 1/20 0.31
▸ PIK3CA P42336 1/20 0.31
▸ PIK3CB P42338 1/20 0.31
▸ PI4KA P42356 1/20 0.31
▸ PIK3CG P48736 1/20 0.31
▸ PI4KB Q9UBF8 1/20 0.31
▸ KCNH2 Q12809 1/20 0.31
▸ ALK Q9UM73 1/20 0.31
▸ LRRK2 Q5S007 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31128996 0.93 ACHE (0.41) ACHEKDM4CKDM4EKDM4AKDM5C
SCHEMBL28426447 0.91 GSK3B (0.34) ACHEKDM4CKDM4EKDM4AKDM5C
SCHEMBL31128982 0.89 LRRK2 (0.37) ALKLRRK2
SCHEMBL25477789 0.76 LOXL2 (0.39) ACHEKDM4CKDM4EKDM4AKDM5C
SCHEMBL3491600 0.73 KDM4C (0.33) KDM4CLRRK2
SCHEMBL11000266 0.72 ACHE (0.41) ACHEKDM4CKDM4EKDM4AKDM5C
SCHEMBL28432117 0.72 GSK3B (0.33) —
SCHEMBL22031498 0.72 ACHE (0.39) ACHEPSMB8PSMB9MPOPIK3CD
SCHEMBL24686656 0.71 EIF2AK4 (0.39) ACHEKDM4CKDM4EKDM4AKDM5C
SCHEMBL22713022 0.70 ACHE (0.39) ACHEKDM4CKDM4EKDM4AKDM5C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025087295-A1 PI3K INHIBITOR, AND PREPARATION METHOD THEREFOR AND USE THEREOF 海创药业股份有限公司 2025-05-01 — — WO disclosed
WO-2024208315-A1 AROMATIC HETEROCYCLIC COMPOUND, AND PREPARATION METHOD THEREFOR AND MEDICAL USE THEREOF 中国医药研究开发中心有限公司 2024-10-10 — — WO disclosed
US-20230043863-A1 HETEROAROMATIC DERIVATIVES FOR USE AS REGULATOR, PREPARATION METHOD THEREFOR AND USE THEREOF SHANGHAI HANSOH BIOMEDICAL CO., LTD. (CN) 2023-02-09 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230043863-A1 HETEROAROMATIC DERIVATIVES FOR USE AS REGULATOR, PREPARATION METHOD THEREFOR AND USE THEREOF WEE2, WEE1, RORB ACHE 4682/4885KDM4C 3157/4885KDM4E 2064/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback